StonvexLoading…
StonvexStonvexStonvexCore line items from MYGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $824.50M | $837.60M | $753.20M | $678.40M |
Operating Income | $-387.20M | $-123.50M | $-257.40M | $-140.60M |
Net Income | $-365.90M | $-127.30M | $-263.30M | $-112.00M |
EPS (Diluted) | $-3.95 | $-1.41 | $-3.18 | $-1.39 |
Total Assets | $706.60M | $1.03B | $1.15B | $1.20B |
Total Liabilities | $338.60M | $326.50M | $363.30M | $312.90M |
Cash & Equivalents | $149.60M | $102.40M | $132.10M | $56.90M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $-151.60M |
Shares Outstanding | 93.50M | 91.30M | 89.90M | 81.20M |